Brief: Charmacy Pharmaceutical Sees Decrease Of 38% To 48% In Net Profit Attributable For Year

Charmacy Pharmaceutical Co

28/02/2022 14:56

Feb 28 (Reuters) - Charmacy Pharmaceutical Co Ltd  2289.HK :
    * SEES DECREASE OF 38% TO 48% IN NET PROFIT ATTRIBUTABLE FOR
YEAR
    * SEES NET PROFIT ATTRIBUTABLE OF APPROXIMATELY RMB21.00
MILLION
TO RMB25.00 MILLION FOR YEAR
    * EXPECTED RESULT DUE TO INCREASE IN ADMINISTRATIVE EXPENSES
AS
DURING YEAR, AMONG OTHERS

Further company coverage:  2289.HK 

 ((reuters.briefs@thomsonreuters.com;))